Patogeneza i niektóre molekularne wskaźniki prognostyczne w raku żołądka
37. Pollack M, Leeuwenburgh C: Molecular mechanisms of oxidative stress in aging: free radicals, aging, antioxidants and disease (part 10). Elsevier Science 1999; 881-923. 38. Gonzalez CA, Pera G, Agudo A et al.: Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer 2003; 107(4): 629-34. 39. Tamura G: Genetic and epigenetic alterations of tumor suppressor and tumor-related genes in gastric cancer. Histol Histopathol 2002; 17(1): 323-29. 40. TakanoY, Kato Y, Saegusa M et al.: The role of the Epstein-Barr virus in the oncogenesis of EBV (+) gastric carcinomas. Virch Arch 1999; 434(1): 1722. 41. Shibata D, Weiss LM: Epstein-Barr virus-associated gastric adenocarcinoma. Am J Patol 1992; 140(4): 769-74. 42. Takada K: Epstein-Barr virus and gastric carcinoma. BMJ 2000; 53(5): 225-61. 43. Nishi M, Ichikawa H, Nakajima T: Gastric cancer – (Epidemiology of stomach cancer). Springer 1993, 2-15. 44. Correa P: A Human Model of Gastric Carcinogenesis. Cancer Res 1988; 48: 3554-60. 45. DeVita VT, Hellman S, Rosenberg SA: Cancerprinciples and practice of oncology. Lippinott-Raven Publishers, 1997; 1, 1021-54. 46. Weisburger JH, Horn CL: Human and laboratory studies on the causes and prevention of gastrointestinal cancer. Scand J Gastroenterol 1985; 104: 15-26. 47. Fenoglio-Preiser CM, Lantz PE, Listrom MB et al.: Gastrointestinal pathology – an atlas and text. Raven Press 1989, 193-223. 48. Charnley G, Tannebaum SR: Flow cytometric analysis of the effect of sodium chloride on gastric cancer risk in the rat. Cancer Res 1985; 45: 5608-16. 49. Kono S, Ikeda M, Ogata M: Salt and geographical mortality of gastric cancer and stroke in Jpn. J Epidemiol Commun Health 1983; 37: 43-46. 50. Mirvish SS: The etiology of gastric cancer. Intragastric nitrosamide formation and other theories. J Natl Cancer Inst 1983; 71: 629-47. 51. Cuello C, Correa P, Haenszel W: Gastric cancer in Columbia. Cancer risk and suspect environmental agents. J Natl Cancer Inst 1976; 57: 1015-20. 52. Fuchs CS, Mayer RJ: Medical Progress: Gastric Carcinoma. New Engl J Med 1995; 333(1): 32-41. 53. Yamaguchi N, Kakizoe K: Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer. Oncology 2001; 2(2): 88-94. 54. Frenck RW, Clemens J: Helicobacter in the developing world. Microbes Infect 2003; 5(8): 705-13. 55. Ueda M, Kikuchi S, Kasugai T et al.: Helicobacter pylori risk associated with childhood home environment. Cancer Sci 2003; 94(10): 914-18. 56. Parsonet J, Friedman GD, Vandersteen DP: Helicobacter pylori infection and the risk of gastric carcinoma. N Eng J Med 1991; 325(16): 1127-31. 57. Kuniyasu H, Yasui W, Yokozaki H et al.: Helicobacter pylori infection and carcinogenesis of the
501
stomach. Langenbeck’s Arch Surg 2000; 385(2): 6974. 58. Asaka M, Kudo M, Kato M et al.: Long-term Helicobacter pylori infection-from gastritis to gastric cancer. Aliment Pharmacol Ther 1998; 1(1): 9-15. 59. Scheiman JM, Cutler A: Helicobacter pylori and Gastric Cancer. Am J Med 1999; 106 (2): 222-26. 60. Vermeer IT, Gerrits MM, Moonen EJ et al.: Helicobacter pylori does not mediate the formation of carcinogenic N-nitrosamines. Helicobacter 2002; 7(3): 163-69. 61. Blaser M, Perez-Perez G, Kleanthous H: Infection with Helicobacter pylori strains possessing cagA is associated with increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55(10): 2111-16. 62. Hunag J, Zheng G, Sumanc K et al.: Meta-Analysis of the Relationship Between cagA Seropositivity and gastric cancer. Gastroenterology 2003; 125(6):1636-44. 63. Yamada H, Aihara T, Okabe S: Mechanism for Helicobacter pylori stimulation of interleukin-8 production in a gastric epithelial cell line (MKN 28): roles of mitogen-activated protein kinase and interleukin-1. Biochem Pharmacol 2001; 61(12):15951604. 64. Yeo M, Park HK, Lee KM et al.: Blockage of HSP 90 modulates Helicobacter pylori-induced IL-8 productions through the inactivation of transcriptional factors of AP-1 and NF-kappaB. Biochem Biophys Res Commun 2004; 320(3): 816-24. 65. Kim JJ, Tao H, Carloni E et al.: Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 2002; 123(2): 542-53. 66. Chan AO, Lam SK, Wong BC et al.: Gene methylation in non-neoplastic mucosa of gastric cancer: age or Helicobacter pylori related? Am J Pathol 2003; 163(1): 370-73. 67. Correa P: Human Gastric Carcinogenesis. A multistep and multifactorial process. First American Cancer Society Award lecture on cancer epidemiology. Cancer Res 1992; 52(24): 6735-40. 68. Blok P, Craanen M, Offerhaus G: Gastric carcinoma: clinical, pathogenic and molecular aspects. QJM 1997; 90(12): 735-49. 69. Baumforth KR, Young L, Flavell K et al.: The Epstein-Barr virus and its association with human cancers. Mol Pathol 1999; 52(6): 307-22. 70. Czopek J, Stojak M, Sińczak A i wsp.: EBV-positive gastric carcinomas in Poland. Pol J Pathol 2003; 54(2): 121-26. 71. Shibata D, Tokunaga M, Uemura Y: Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol 1991; 139; 469-74. 72. Hsu JL, Glaser SL: Epstein–Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol 2000; 34(1): 27-53. 73. Kang GH, Lee S, Kim WH et al.: Epstein-barr virus-positive gastric carcinoma demonstrates fre-